Centiva Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51,800
Closed -$3.51M 1638
2025
Q1
$3.51M Sell
51,800
-58,200
-53% -$3.48M 0.11% 93
2024
Q4
$4.94M Buy
110,000
+88,500
+412% +$4.96M 0.1% 99
2024
Q3
$1.35M Buy
21,500
+10,700
+99% +$624K 0.03% 670
2024
Q2
$638K Buy
+10,800
New +$676K 0.01% 1006
2024
Q1
Sell
-900
Closed -$71.1K 1857
2023
Q4
$71.1K Buy
+900
New +$64.1K ﹤0.01% 1619
2023
Q3
Sell
-20,000
Closed -$1.38M 1767
2023
Q2
$1.38M Sell
20,000
-20,000
-50% -$1.42M 0.03% 489
2023
Q1
$2.97M Buy
40,000
+30,000
+300% +$2.52M 0.07% 289
2022
Q4
$932K Hold
10,000
0.03% 588
2022
Q3
$954K Buy
+10,000
New +$990K 0.02% 646
2022
Q1
Sell
-20,000
Closed -$2.06M 1658
2021
Q4
$2.06M Buy
20,000
+18,000
+900% +$1.66M 0.04% 362
2021
Q3
$170K Sell
2,000
-28,000
-93% -$2.35M 0.01% 960
2021
Q2
$2.5M Buy
+30,000
New +$2.46M 0.06% 271
2020
Q2
Sell
-4,100
Closed -$243K 694
2020
Q1
$243K Sell
4,100
-116,400
-97% -$7.77M 0.01% 419
2019
Q4
$8.95M Buy
120,500
+20,500
+21% +$1.44M 0.44% 44
2019
Q3
$6.31M Buy
+100,000
New +$5.93M 0.39% 45

Other funds holding CVS

Centiva Capital's CVS Position: Q1 2026 in Review

Centiva Capital increased its CVS Health (CVS) stake by 915% in Q1 2026, buying an estimated $8.34M and bringing the position to 120,089 shares worth $8.62M. The position accounts for 0.06% of the portfolio, ranked #198.

Centiva Capital first reported a position in CVS in Q1 2019 and has held it in 21 quarters since. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Centiva Capital held 120,089 shares of CVS Health worth $8.62M as of Q1 2026.
  • Centiva Capital bought 108,252 CVS Health shares in Q1 2026, an estimated $8.34M.
  • CVS Health made up 0.06% of Centiva Capital's portfolio in Q1 2026, its #198 holding.
  • Centiva Capital first reported a position in CVS Health in Q1 2019 and has held it in 21 quarters since.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.